Ropark XL 6 mg Tablet

Ropark XL 6 mg Tablet is a prolonged-release tablet containing 6 mg of ropinirole in each tablet. It belongs to the anti-Parkinsonian medicine class and is used to help manage symptoms of Parkinson’s disease. This strength is intended for patients who have already been assessed by a doctor and need a higher ropinirole dose as part of their ongoing treatment plan. Ropark XL 6 mg Tablet is taken by mouth and is designed to release the medicine gradually over time.

How it works: Ropinirole works by stimulating dopamine receptors in the brain, helping replace some of the low dopamine activity seen in Parkinson’s disease. As a tablet, Ropark XL 6 mg Tablet is swallowed whole so it can release ropinirole gradually and help smooth symptom control over the day.

Ropark XL 6 mg Tablet is a higher-strength option compared with Ropark XL 1 mg Tablet, Ropark XL 2 mg Tablet, and Ropark XL 4 mg Tablet. It may be chosen for patients who need more symptom control after lower strengths have been adjusted upward and tolerated. Because it is a 6 mg prolonged-release tablet, it should not be treated like a starting dose unless a clinician specifically prescribes it.

• Parkinson’s disease symptom control
• Help with tremor and stiffness
• Help with slowness of movement
• Adjunct treatment when a doctor prescribes ropinirole extended-release therapy

• Swallow Ropark XL 6 mg Tablet whole with water; do not crush, split, or chew it.
• Take it exactly at the time your doctor prescribes, usually once daily for the extended-release form.
• You may take it with or without food, but taking it with food can help reduce nausea.
• If you miss a dose, follow your prescriber’s instructions; do not double up unless told to do so.
• Check the tablet before use and keep it in its original strip/box until you are ready to take it.

Each Ropark XL 6 mg Tablet provides 6 mg of ropinirole in a single prolonged-release tablet. The doctor decides how often it should be taken, and this strength is generally used as part of individualized dose adjustment rather than as an automatic starting dose. For Parkinson’s disease, the total daily dose must not exceed the maximum set by the prescriber, and patients should not increase the dose on their own.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Ropinirole may include:

• Nausea
• Sleepiness or drowsiness
• Dizziness
• Headache
• Constipation
• Tiredness
• Swelling in the legs or feet

• Ropark XL 6 mg Tablet is a higher-strength tablet, so dose changes should be made only under medical supervision.
• It can cause dizziness, low blood pressure, and fainting, especially when standing up quickly.
• Avoid driving or operating machinery until you know how this 6 mg tablet affects you.
• Alcohol may worsen drowsiness and dizziness.
• Tell your doctor if you have heart disease, blood pressure problems, kidney disease, or liver disease.
• Tell your doctor if you have a history of hallucinations, impulse-control problems, or sleep attacks.
• Do not stop Ropark XL 6 mg Tablet suddenly unless your doctor tells you to do so.

• Other medicines that cause sleepiness, such as opioids, sleep aids, or benzodiazepines
• Antipsychotic medicines and some anti-nausea medicines that may reduce ropinirole’s effect
• Estrogens, which can change ropinirole levels in some patients
• Alcohol, which can increase dizziness and drowsiness
• CYP1A2 inhibitors such as ciprofloxacin, which can raise ropinirole exposure

Store Ropark XL 6 mg Tablet in its original strip/box at room temperature, away from moisture, heat, and direct light.